Lifeward (LFWD) EBT Growth (3y) (2018 - 2026)
Lifeward (LFWD) EBT Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 17.92% |
| 10 | Lifeward | 20.56 Mn | 11.11 Mn | 2.71 Mn | -35.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.91% |
| Dec 31, 2025 | -3.17% |
| Sep 30, 2025 | 16.51% |
| Jun 30, 2025 | -14.08% |
| Mar 31, 2025 | -3.80% |
| Dec 31, 2024 | -58.95% |
| Sep 30, 2024 | -4.35% |
| Jun 30, 2024 | -11.13% |
| Mar 31, 2024 | -27.61% |
| Dec 31, 2023 | -24.27% |
| Sep 30, 2023 | -31.51% |
| Jun 30, 2023 | -18.18% |
| Mar 31, 2023 | -3.75% |
| Dec 31, 2022 | -11.38% |
| Sep 30, 2022 | -17.02% |
| Jun 30, 2022 | 1.24% |
| Mar 31, 2022 | -2.60% |
| Dec 31, 2021 | 8.87% |
| Sep 30, 2021 | 15.95% |
| Jun 30, 2021 | 18.56% |